Khemla, Supphachoke, Atibordee Meesing, Wantin Sribenjalux, and Ploenchan Chetchotisakd. “Lipid Profiles of People With Human Immunodeficiency Virus With Dyslipidemia After Switching from Efavirenz to Dolutegravir”. Drug Target Insights 17, no. 1 (April 28, 2023): 45–53. Accessed November 5, 2024. https://journals.aboutscience.eu/index.php/dti/article/view/2529.